Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Superficial Bladder Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06919965
What this trial is testing

Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC 220
Early research (Phase 1)Study completedNCT00782587
What this trial is testing

Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
Halozyme Therapeutics 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT04917809
What this trial is testing

Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer

Who this might be right for
Bladder CancerRecurrent Bladder CancerFGFR3 Gene Mutation
Memorial Sloan Kettering Cancer Center 20
Early research (Phase 1)UnknownNCT06632964
What this trial is testing

A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
The Affiliated Hospital of Xuzhou Medical University 16
Testing effectiveness (Phase 2)Looking for participantsNCT06503614
What this trial is testing

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerNon-Muscle Invasive Bladder Urothelial Carcinoma
John Sfakianos 60
Testing effectiveness (Phase 2)Looking for participantsNCT06663137
What this trial is testing

Evaluate the Safety and Efficacy of NDV-01 in Participants With NMIBC

Who this might be right for
Non Muscle Invasive Bladder Cancer
Relmada Therapeutics, Inc. 70
Not applicableLooking for participantsNCT07309445
What this trial is testing

Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

Who this might be right for
Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC 150
Post-approval studies (Phase 4)UnknownNCT02443844
What this trial is testing

Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression

Who this might be right for
Bladder Cancer
Diskapi Teaching and Research Hospital 40
Not applicableUnknownNCT03597087
What this trial is testing

The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study

Who this might be right for
Bladder Cancer
Seoul National University Hospital 289
Large-scale testing (Phase 3)Study completedNCT02773849
What this trial is testing

ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Superficial Bladder Cancer
Ferring Pharmaceuticals 157
Large-scale testing (Phase 3)Ended earlyNCT01310803
What this trial is testing

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

Who this might be right for
Carcinoma in SituTransitional Cell CarcinomaNon-muscle Invasive Bladder Cancer
Endo USA Inc., a Keenova Therapeutics Company 1
Not applicableEnded earlyNCT04412070
What this trial is testing

Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients

Who this might be right for
Bladder Cancer
Hopital Foch 20
Not applicableStudy completedNCT05290623
What this trial is testing

High-power Green-light Laser Endoscopic Submucosal Dissection for Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Shandong Provincial Hospital 45
Not applicableEnded earlyNCT01108003
What this trial is testing

Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery

Who this might be right for
Recurrent Bladder CancerStage 0 Bladder CancerStage I Bladder Cancer+2 more
Roswell Park Cancer Institute 7
Testing effectiveness (Phase 2)Looking for participantsNCT06732531
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerNon Muscle Invasive
Zhuhai Beihai Biotech Co., Ltd 48
Large-scale testing (Phase 3)Ended earlyNCT02106572
What this trial is testing

Therapeutic Instillation of Mistletoe

Who this might be right for
Superficial Bladder Cancer
Abnoba Gmbh 174
Large-scale testing (Phase 3)Study completedNCT07279792
What this trial is testing

Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNonmuscle Invasive Bladder CancerIrrigation+3 more
Ain Shams University 150
Large-scale testing (Phase 3)Study completedNCT05136898
What this trial is testing

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 8
Large-scale testing (Phase 3)Ended earlyNCT04688931
What this trial is testing

UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 282
Testing effectiveness (Phase 2)Study completedNCT00191711
What this trial is testing

Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.

Who this might be right for
Superficial Bladder Cancer
Eli Lilly and Company 43
Next Page